Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Venous Thromboembolism
Interventions
DRUG

Rivaroxaban

15mg twice daily for 3 weeks after operation, later 20mg once daily until 3 months after the filter is removed. Application: oral

DRUG

Warfarin

3mg for 5 days after the operation, later 0.75mg to 18mg depending on INR (2.0-3.0) until until 3 months after the filter is removed. Frequency: once daily Application: oral

DRUG

Nadroparin

Dose: 1mg/kg Duration: 5 days after the operation Frequency: twice daily Application: subcutaneous

Trial Locations (7)

200000

RECRUITING

Huadong Hospital affiliated to Fudan University, Shanghai

RECRUITING

Shanghai 5th People's Hospital, Shanghai

RECRUITING

Zhongshan Hospital affiliated to Fudan University, Shanghai

230000

RECRUITING

Anhui Provincial Hospital, Hefei

264000

RECRUITING

Yantai Yuhuangding Hospital, Yantai

310000

RECRUITING

Sir Run Run Shaw Hospital, Hangzhou

RECRUITING

The second affiliated hospital of zhejiang university school of medicine, Hangzhou

All Listed Sponsors
collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

Huadong Hospital

OTHER

collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Shanghai 5th People's Hospital

OTHER

collaborator

Yantai Yuhuangding Hospital

OTHER

collaborator

Anhui Provincial Hospital

OTHER_GOV

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER